PCH
ORIC icon

Polar Capital Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

Polar Capital Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.83M Buy
539,377
+37,013
+7% +$420K 0.02% 205
2025
Q4 		$4.11M Buy
502,364
+33,754
+7% +$389K 0.02% 233
2025
Q3 		$5.62M Buy
+468,610
New +$4.93M 0.03% 218

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Polar Capital Holdings's ORIC Position: Q1 2026 in Review

Polar Capital Holdings increased its Oric Pharmaceuticals (ORIC) stake by 7.4% in Q1 2026, buying an estimated $420K and bringing the position to 539,377 shares worth $6.83M. The position accounts for 0.02% of the portfolio, ranked #205.

Polar Capital Holdings first reported a position in ORIC in Q3 2025 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Polar Capital Holdings held 539,377 shares of Oric Pharmaceuticals worth $6.83M as of Q1 2026.
  • Polar Capital Holdings bought 37,013 Oric Pharmaceuticals shares in Q1 2026, an estimated $420K.
  • Oric Pharmaceuticals made up 0.02% of Polar Capital Holdings's portfolio in Q1 2026, its #205 holding.
  • Polar Capital Holdings first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Polar Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.